Share This

Topics Comments
 < Previous page    Next page > 
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
Alibaba Health Information Technology Limited 2021-12-31T15:00 財經茄呢啡 藍籌匯控微升０．１％；騰訊升０．２％；美團升０．７％；京東揚２％；但阿里巴巴跌０．５％；旗下阿里健康降１．１％，暫錄五連跌；吉利跌１．２％；舜宇下挫０．５％；瑞聲挫２．５％。
Alibaba Health Information Technology Limited 2021-12-31T15:00 財經茄呢啡 藥店經理人在企查查更新的信息中發現，阿里健康大藥房醫藥連鎖有限公司（以下簡稱阿里健康大藥房）今星期新增了雙雙對外投資，新增投資企業為阿里健康大藥房合肥有限公司，投資比例１００％。
Alibaba Health Information Technology Limited 2021-12-24T14:40 財經茄呢啡 對於這次業績虧損，阿里健康解釋了多方面原因，一是公司增長了一系列創新業務，如醫鹿ＡＰＰ、本地醫療、健康險等增長了配置；二是在藥品倉儲物流等藥品供給鏈能力以及醫藥自營業務精細化運營，用戶復診開方體驗、處方藥合規安全等方面的技術研發持續投入；三是在天貓醫藥平台和阿里健康大藥房品牌心智建設加大投入；四是因增長線上Ｂ２Ｃ藥品銷售市占率、加速處方藥業務布局並相應增長市場投放帶來的自營業務盈息口調低。
Alibaba Health Information Technology Limited 2021-12-24T14:40 財經茄呢啡 港股醫藥電商龍頭阿里健康收跌逾４％報６．６２港元/股，總市值８９３億港元。盤中，阿里健康股價一度跌超５％，報６．５５港元/股的５２周新低。
Alibaba Health Information Technology Limited 2021-12-17T15:18 財經茄呢啡 作為一家以互聯網技術為底色的科技公司，近年來，阿里健康一直致力於依托互聯網技術，有幫推動優質醫療、醫藥資源向基層下沉。前不久，在第九屆中國公益慈善項目交流展示會，阿里健康還宣布，和中國出生缺陷干預救助基金會、中國社會福利基金會合作，對重疾兒童的救助拓展到更多覆蓋區域及病種。作為社會補充力量，繼續用互聯網的形式，把社會責任融入產品、技術及服務之中。
Alibaba Health Information Technology Limited 2021-12-17T15:18 財經茄呢啡 １２月１４日，阿里健康大藥房（成都）有限公司成立，法定代表人桂楓，注冊資本２００萬人幣，經營范圍包括藥品零售；藥品批發；第三類醫療器械經營；食品銷售；消毒器械銷售等。股東信息顯示，該公司由阿里健康大藥房醫藥連鎖有限公司全資控股。
Alibaba Health Information Technology Limited 2021-12-17T15:18 財經茄呢啡 中期業績發表後，多家大行均降低阿里健康預計，摩根大通相信，阿里健康上半年的業績疲軟，擔憂內地對互聯網醫療保健行業的管控收緊，會損害公司在線醫療服務並令在線處方藥銷售增加放緩，該行雖保持對阿里健康２０２２至２０２４財年實現３０％以上收入復合年增加率的預計，但料要到２０２４財年才有望錄得淨盈利，較原先預計推遲一年，相信公司增加前景黯淡，重申「中性」評級之余，將其目標價由９元降至８元。
Alibaba Health Information Technology Limited 2021-12-10T14:28 財經茄呢啡 阿里健康２０２２財年中期營收９３．６億元人民幣，其中，醫藥自營業務和醫藥電商平台業務分別創收８１．１９億元和１０．１億元，分別占總營收８６．７６％、１０．８％；期內經調整後虧損２．８３億元，去年同期為利潤４．３６億元。據官方說法，此次阿里健康由盈轉虧為開拓創新業務所致。
Alibaba Health Information Technology Limited 2021-12-10T14:28 財經茄呢啡 市場對阿里健康心理悲觀。重要系阿里健康去年並表阿里巴巴控股的全資附屬公司ＡＬＩ ＪＫ ＮＵＴＲＩＴＩＯＮＡＬ ＰＲＯＤＵＣＴＳ帶來業績增量，及新冠疫情期間購藥需求激增帶來業績高基數。在高基數效應下，２０２１年阿里健康收入增速放緩幅度較大，伴隨支出增長，出現虧損所致。
Alibaba Health Information Technology Limited 2021-12-03T14:19 財經茄呢啡 背靠阿里巴巴，阿里健康上市以來在資產和流量方面取得了有力的增益，營收快速增加。２４日，阿里健康公布中期業績，上半年營收９３．６億元，同比增加３１％。然而「增收不增利」的困境難以擺脫，阿里健康上半年由盈轉虧，淨虧損達到２．３１８億元。巨大的資產等投入，未能讓阿里健康在短期內迎來穩定持續的回報。
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.